tiprankstipranks
Zelira Therapeutics Issues 3.5 Million Convertible Notes
Company Announcements

Zelira Therapeutics Issues 3.5 Million Convertible Notes

Zelira Therapeutics (AU:ZLD) has released an update.

Pick the best stocks and maximize your portfolio:

Zelira Therapeutics Limited has announced the issuance of 3.5 million unquoted convertible notes as part of previously disclosed transactions. These securities are not intended to be quoted on the Australian Securities Exchange. Investors may find this development indicative of the company’s strategic financial maneuvers.

For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskZelira Therapeutics Issues Convertible Notes
TipRanks Australian Auto-Generated NewsdeskZelira Therapeutics Unveils Growth Plans at Investment Conference
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App